ANPEP and Disorder of lipid metabolism: In glucose and lipid metabolism disorders, lipid accumulation can lead to low-grade chronic inflammation; APN treatment can mitigate inflammation by inhibiting NF-κB-related pathways, thereby downregulating inflammatory factors such as TNF-α and interleukin (IL)-6.